Biotechnology
Compare Stocks
4 / 10Stock Comparison
BTX vs DBVT vs ALKS vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Drug Manufacturers - Specialty & Generic
BTX vs DBVT vs ALKS vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Biotechnology | Biotechnology | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market Cap | $945M | $1712.35T | $5.90B | $1.61B |
| Revenue (TTM) | $41M | $0.00 | $1.56B | $4.18B |
| Net Income (TTM) | $36M | $-168M | $153M | $-1.82B |
| Gross Margin | 100.0% | — | 65.4% | 34.2% |
| Operating Margin | 87.7% | — | 12.3% | -4.1% |
| Forward P/E | 47.6x | — | 24.8x | 5.6x |
| Total Debt | $0.00 | $22M | $70M | $3.97B |
| Cash & Equiv. | — | $194M | $1.12B | $532M |
BTX vs DBVT vs ALKS vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| BlackRock Technolog… (BTX) | 100 | 39.9 | -60.1% |
| DBV Technologies S.… (DBVT) | 100 | 37.5 | -62.5% |
| Alkermes plc (ALKS) | 100 | 189.5 | +89.5% |
| Perrigo Company plc (PRGO) | 100 | 29.0 | -71.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BTX vs DBVT vs ALKS vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BTX has the current edge in this matchup, primarily because of its strength in quality and dividends.
- 87.7% margin vs PRGO's -43.5%
- 10.6% yield, 1-year raise streak, vs PRGO's 9.8%, (2 stocks pay no dividend)
DBVT is the clearest fit if your priority is momentum.
- +110.4% vs PRGO's -51.2%
ALKS is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
- -11.0% 10Y total return vs BTX's -37.6%
- Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
- Beta 1.06, current ratio 3.55x
PRGO is the clearest fit if your priority is income & stability.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- -2.8% revenue growth vs DBVT's -100.0%
- Lower P/E (5.6x vs 24.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.8% revenue growth vs DBVT's -100.0% | |
| Value | Lower P/E (5.6x vs 24.8x) | |
| Quality / Margins | 87.7% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 1.06 vs BTX's 1.29 | |
| Dividends | 10.6% yield, 1-year raise streak, vs PRGO's 9.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +110.4% vs PRGO's -51.2% | |
| Efficiency (ROA) | 5.4% ROA vs DBVT's -89.0% |
BTX vs DBVT vs ALKS vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BTX vs DBVT vs ALKS vs PRGO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKS leads in 2 of 6 categories
BTX leads 1 • PRGO leads 1 • DBVT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BTX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. BTX is the more profitable business, keeping 87.7% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $41M | $0 | $1.6B | $4.2B |
| EBITDAEarnings before interest/tax | — | -$112M | $212M | $58M |
| Net IncomeAfter-tax profit | — | -$168M | $153M | -$1.8B |
| Free Cash FlowCash after capex | — | -$151M | $392M | $108M |
| Gross MarginGross profit ÷ Revenue | +100.0% | — | +65.4% | +34.2% |
| Operating MarginEBIT ÷ Revenue | +87.7% | — | +12.3% | -4.1% |
| Net MarginNet income ÷ Revenue | +87.7% | — | +9.8% | -43.5% |
| FCF MarginFCF ÷ Revenue | +6.8% | — | +25.1% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | +28.2% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +91.5% | -4.1% | -56.4% |
Valuation Metrics
PRGO leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 24.8x trailing earnings, ALKS trades at a 48% valuation discount to BTX's 47.6x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than BTX's 26.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $945M | $1712.35T | $5.9B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $945M | $1712.35T | $4.9B | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | 47.65x | -0.76x | 24.76x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 5.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 26.48x | — | 17.25x | 7.42x |
| Price / SalesMarket cap ÷ Revenue | 23.23x | — | 4.00x | 0.38x |
| Price / BookPrice ÷ Book value/share | 0.98x | 0.66x | 3.28x | 0.55x |
| Price / FCFMarket cap ÷ FCF | 3.41x | — | 12.28x | 11.12x |
Profitability & Efficiency
ALKS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs BTX's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.9% | -130.2% | +8.8% | -50.7% |
| ROA (TTM)Return on assets | +1.8% | -89.0% | +5.4% | -19.8% |
| ROICReturn on invested capital | +1.4% | — | +18.9% | +3.7% |
| ROCEReturn on capital employed | +1.8% | -145.7% | +14.2% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 7 | 4 |
| Debt / EquityFinancial leverage | — | 0.13x | 0.04x | 1.35x |
| Net DebtTotal debt minus cash | $0 | -$172M | -$1.0B | $3.4B |
| Cash & Equiv.Liquid assets | — | $194M | $1.1B | $532M |
| Total DebtShort + long-term debt | $0 | $22M | $70M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | 2313.25x | -189.82x | 32.30x | -7.20x |
Total Returns (Dividends Reinvested)
ALKS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors BTX at 12.8% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.2% | +4.9% | +25.3% | -13.5% |
| 1-Year ReturnPast 12 months | +37.7% | +110.4% | +16.5% | -51.2% |
| 3-Year ReturnCumulative with dividends | +43.5% | +19.7% | +14.5% | -58.1% |
| 5-Year ReturnCumulative with dividends | -38.0% | -69.1% | +60.9% | -60.1% |
| 10-Year ReturnCumulative with dividends | -37.6% | -87.0% | -11.0% | -77.7% |
| CAGR (3Y)Annualised 3-year return | +12.8% | +6.2% | +4.6% | -25.2% |
Risk & Volatility
Evenly matched — BTX and ALKS each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than BTX's 1.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTX currently trades 98.5% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.29x | 1.26x | 1.06x | 1.18x |
| 52-Week HighHighest price in past year | $8.22 | $26.18 | $36.60 | $28.44 |
| 52-Week LowLowest price in past year | $6.13 | $7.53 | $25.17 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +76.3% | +96.7% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 73.3 | 48.1 | 60.2 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 727K | 252K | 2.3M | 3.4M |
Analyst Outlook
Evenly matched — BTX and PRGO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DBVT as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). For income investors, BTX offers the higher dividend yield at 10.56% vs PRGO's 9.81%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $46.33 | $44.00 | $20.00 |
| # AnalystsCovering analysts | — | 15 | 28 | 36 |
| Dividend YieldAnnual dividend ÷ price | +10.6% | — | — | +9.8% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 10 |
| Dividend / ShareAnnual DPS | $0.86 | — | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.8% | 0.0% | +0.5% | 0.0% |
ALKS leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). BTX leads in 1 (Income & Cash Flow). 2 tied.
BTX vs DBVT vs ALKS vs PRGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BTX or DBVT or ALKS or PRGO a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BTX or DBVT or ALKS or PRGO?
On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.
8x versus BlackRock Technology and Private Equity Term Trust at 47. 6x.
03Which is the better long-term investment — BTX or DBVT or ALKS or PRGO?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.
9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BTX or DBVT or ALKS or PRGO?
By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.
06β versus BlackRock Technology and Private Equity Term Trust's 1. 29β — meaning BTX is approximately 21% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — BTX or DBVT or ALKS or PRGO?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). On earnings-per-share growth, the picture is similar: Alkermes plc grew EPS -34. 1% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BTX or DBVT or ALKS or PRGO?
BlackRock Technology and Private Equity Term Trust (BTX) is the more profitable company, earning 87.
7% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 87. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTX leads at 87. 7% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — BTX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BTX or DBVT or ALKS or PRGO more undervalued right now?
Analyst consensus price targets imply the most upside for DBVT: 131.
8% to $46. 33.
08Which pays a better dividend — BTX or DBVT or ALKS or PRGO?
In this comparison, BTX (10.
6% yield), PRGO (9. 8% yield) pay a dividend. DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.
09Is BTX or DBVT or ALKS or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BTX and DBVT and ALKS and PRGO?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BTX is a small-cap income-oriented stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. BTX, PRGO pay a dividend while DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.